Gut bacteria diversity, digestive health, probiotics, prebiotics, and the gut-brain axis
361 artigos
Harvard researchers find lasting microbiome and metabolome shifts after adenoma resection that mirror colorectal cancer signatures.
A landmark review reveals how diet, gut bacteria, and their metabolites determine the success of immune checkpoint blockade cancer therapy.
A corrigendum updates the EEDBI Consortium's mucosal investigation of environmental enteric dysfunction published in 2024.
A case report from China documents atypical diarrhea in an immunocompetent infant, raising questions about rare GI diagnoses in young children.
Aging disrupts gut microbiota and mTOR signaling, crippling vaccine responses — but targeted interventions may reverse this.
Gut microbes deploy reversible DNA methylation changes to adapt to antibiotics and fecal transplants — even beneficial Akkermansia uses this strategy.
A fetal enzyme floods newborns with hyocholic acids that train immune tolerance and shape a healthy gut microbiome—then disappear by adulthood.
A receptor that keeps firing inside pain cells may explain why IBS discomfort is so persistent and hard to treat.
A completed trial tested whether probiotic and prebiotic supplementation could reduce premature aging-related inflammation in people living with HIV.
Age-related shifts in intestinal T cell populations may silently erode gut barrier function, accelerating the chronic inflammation that drives aging diseases.
A new microbial gene atlas of infant nasopharyngeal swabs maps how cystic fibrosis and clinical interventions alter early respiratory microbiomes.
Candida albicans and Group B Streptococcus form a dangerous partnership in the vaginal tract, boosting bacterial virulence and antibiotic resistance.
